Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo Controlled Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Early Alzheimer's Disease (FEAD)

NCT06362707 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT06362707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06362707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo Controlled Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Early Alzheimer's Disease (FEAD)
Lead sponsor
Helse Stavanger HF
Phase
Phase 2
Overall status
Recruiting
Start date
August 1, 2024
Completion date
January 1, 2028
Enrollment
200 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive decline, mild